Steven Simoens

KU Leuven — Belgium

Economics, Econometrics and Finance · Social Sciences

63h-index15.7kcitations688works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(339), Pharmaceutical Economics and Policy(304), Biosimilars and Bioanalytical Methods(110), Pharmaceutical studies and practices(90), Pharmaceutical Practices and Patient Outcomes(56)

Publications687 total

Ensuring Epidemiological Consistency in Risk-Stratified Cancer Screening Models: A Novel Approach Based on Flemish Breast Cancer Screening
Applied Health Economics and Health Policy·2026
HPR157 Paying for Advanced Therapy Medicinal Products: Are Spreading Payments Over Time the Solution?
Value in Health·2025
CO6 Addressing Clinical Uncertainties in ATMP Reimbursement: A Review of European Methodological Guidelines and Practices
Value in Health·2025
SA45 Gaps in JCA Guidance for Systematic Literature Reviews: A Comparative Review with Cochrane, EUnetHTA, and Major HTA Agencies' Standards
Value in Health·2025
The health production model and the crucial role of health promotion
Expert Review of Pharmacoeconomics & Outcomes Research·2025Open Access
Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study
BioDrugs·2025Open Access
Preferences for gene therapy in Duchenne muscular dystrophy: insights from patient and caregiver interviews and attribute development
Frontiers in Pharmacology·2025Open Access
Epistemological Tensions in the EU HTA Joint Clinical Assessment: The Illusion of Judgment-Free Evaluation
Preprints.org·2025Open Access
Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies
Frontiers in Pharmacology·2025Open Access
Barriers to adoption of biosimilar insulins in Europe: A mixed‐methods study
Diabetes Obesity and Metabolism·2025· 1 citedOpen Access
Advanced therapy medicinal products are coming of age: A pipeline analysis of the clinical trial landscape
Drug Discovery Today·2025· 1 citedOpen Access
The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies
Frontiers in Pharmacology·2025Open Access
The European Union’s Health Technology Assessment Regulation (EU-HTA R) Will Prosper Despite Major Setbacks
Preprints.org·2025Open Access
Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordability
Frontiers in Pharmacology·2025Open Access
Evaluating the Cost-Effectiveness of Air Pollution Mitigation Strategies: A Systematic Review
International Journal of Environmental Research and Public Health·2025· 3 citedOpen Access
Between Rigor and Relevance: Why the EU Hta Guidelines on Indirect Comparisons Miss the Mark
Preprints.org·2025Open Access
Evolving global regulatory landscape for approval of biosimilars: current challenges and opportunities for convergence
Expert Opinion on Biological Therapy·2025· 7 cited
Cost-Effectiveness of Strategies Addressing Environmental Noise: A Systematic Literature Review
International Journal of Environmental Research and Public Health·2025· 1 citedOpen Access
The EU-Joint Clinical Assessment Guidance Documents Fail to Address the Significance of Systematic Literature Reviews and Deviate from the State of the Art
Preprints.org·2025Open Access
Joint Clinical Assessment in the EU HTA Regulation – Would Drugs Supported by Single-Arm Trials Fit Under Evaluation?
Preprints.org·2025Open Access
page 1 of 35Next →

Frequent Co-authors

Isabelle Huys(13), Arnold G. Vulto(8), Carmen D. Dirksen(5), Thomas D’Hooghe(5), Pieter Dylst(5), Brian Godman(5), Ott Laius(5), Jurij Fürst(5), Lone Hummelshøj(4), Gisbert Selke(4), Corrine Zara(4), Anna Bucsics(4), Minne Casteels(4), G.A.J. Dunselman(3), Iris Brandes(3), Evelien Moorkens(3), Laura McCullagh(3), Patricia Vella Bonanno(3), Magdalena Władysiuk(3), Marija Kalaba(3)